McDonald's Tests High-Protein Menu as GLP-1 User Surge
McDonald's says it's testing high-protein menu items to appeal to customers using GLP-1 weight-loss medications. The move highlights a broader industry shift toward GLP-1-friendly options as demand and pricing pressures reshape quick-service menus.
Key Takeaways
- McDonald's is testing high-protein items to attract GLP-1 users.
- Q4 2025 revenue rose to $6.83 billion with EPS of $3.05 per share.
- A $5 meal deal helped U.S. same-store sales rise 9% in the quarter.
- Shake Shack and major CPG firms are launching GLP-1-friendly options.
- McDonald's stock rose about 5% over the past month on stronger U.S. traffic.
People Involved
- Chris KempczinskiMcDonald's CEO
- Jill McDonaldMcDonald's Vice President
Entities Involved
- McDonald's CorpFast-food operator and the subject of the move
- Shake Shack IncPeer launching GLP-1 friendly options
- Conagra BrandsCPG company offering smaller portions labeled GLP-1 friendly
- General MillsCPG company offering GLP-1 friendly options
MarketMoodz Analysis
For investors, the push toward GLP-1 friendly menus could shift traffic and mix in a way that favors higher-margin, protein-forward items if demand holds. It also implies potential supply-chain and pricing considerations as restaurants calibrate portions, beverage offers, and promotions to meet new consumer preferences without eroding price discipline.
The trend sits within a broader context of rising grocery costs and inflation, pressuring value-focused dining vs. away-from-home demand. Historically, quick-service players that can align menus with evolving health and wellness trends tend to see improved basket size and repeat visits, but execution—especially around pricing and portion control—will be critical as more brands flirt with GLP-1 messaging.
Source: Original Article
Get AI-Powered Market Insights
Stay ahead of market-moving events with our real-time analysis and stock ratings.
Start Your Free Trial
MarketMoodz